TruScreen Group Limited (ASX:TRU)

Australia flag Australia · Delayed Price · Currency is AUD
0.0130
-0.0020 (-13.33%)
Mar 17, 2026, 11:17 AM AEST
Market Cap10.53M -29.7%
Revenue (ttm)1.60M -32.0%
Net Income-2.16M
EPS-0.00
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,932,292
Average Volume310,000
Open0.0130
Previous Close0.0150
Day's Range0.0130 - 0.0130
52-Week Range0.0120 - 0.0290
Beta-0.16
RSI49.49
Earnings DateFeb 27, 2026

About TruScreen Group

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and the Middle East/North Africa. It offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. TruScreen Group Limited was incorporated in... [Read more]

Sector Healthcare
Founded 2013
Country New Zealand
Stock Exchange Australian Securities Exchange
Ticker Symbol TRU
Full Company Profile

Financial Performance

In fiscal year 2025, TruScreen Group's revenue was 2.07 million, a decrease of -20.28% compared to the previous year's 2.60 million. Losses were -2.24 million, 9.41% more than in 2024.

Financial numbers in NZD Financial Statements